Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort study
US National Institutes of Health (NIH) Clinical Center; US National Cancer Institute; the Intramural Research Program of the US National Heart, Lung, and Blood Institute; the US National Institute of Allergy and Infectious Diseases; and the US Food and Drug Administration.
Authors
- Jonathan Baghdadi (ORCID: https://orcid.org/0000-0002-2442-0654)
- Sadia Sarzynski
- Katherine E Goodman (ORCID: https://orcid.org/0000-0003-2851-775X)
- Bruce Swihart (ORCID: https://orcid.org/0000-0002-4216-9942)
- Morgan Walker (ORCID: https://orcid.org/0000-0002-4699-6777)
- John H Powers
- Chanu Rhee
- Michael Klompas
- Sarah Warner
- Sameer S Kadri
- Anthony D Harris
- Christina Yek
Institutions
- University of Maryland, Baltimore (US)
- National Heart, Lung, and Blood Institute (US)
- Harvard Pilgrim Health Care (US)
- National Institute of Allergy and Infectious Diseases (US)
- National Institutes of Health Clinical Center (US)
Publication Details
- Journal
- The Lancet Infectious Diseases
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/s1473-3099(26)00020-4
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00